Literature DB >> 27821518

Attention deficit hyperactivity disorder: overdiagnosed or diagnoses missed?

Eric Taylor.   

Abstract

The prevalence of attention deficit hyperactivity disorder is about 5% of the child population, and it carries risks for mental health, educational and personal dysfunction, antisociality and death. The diagnosis in practice is made with remarkable differences in frequency between nations. Low rates in the UK, by comparison with research estimates, suggest that the condition may often be missed in clinical practice; the reasons are considered. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  ADHD; Diagnosis; Hyperkinetic disorder; Prevalence

Mesh:

Year:  2016        PMID: 27821518     DOI: 10.1136/archdischild-2016-310487

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  11 in total

1.  What Differentiates Children with ADHD Symptoms Who Do and Do Not Receive a Formal Diagnosis? Results from a Prospective Longitudinal Cohort Study.

Authors:  Cliodhna O'Connor; Fiona McNicholas
Journal:  Child Psychiatry Hum Dev       Date:  2020-02

Review 2.  Do Omega-3/6 Fatty Acids Have a Therapeutic Role in Children and Young People with ADHD?

Authors:  E Derbyshire
Journal:  J Lipids       Date:  2017-08-30

3.  Long-term study of lisdexamfetamine dimesylate in Japanese children and adolescents with attention-deficit/hyperactivity disorder.

Authors:  Hironobu Ichikawa; Tasuku Miyajima; Yushiro Yamashita; Masakazu Fujiwara; Akimasa Fukushi; Kazuhiko Saito
Journal:  Neuropsychopharmacol Rep       Date:  2019-12-08

4.  Prevalence and comorbidity of attention deficit hyperactivity disorder in Spain: study protocol for extending a systematic review with updated meta-analysis of observational studies.

Authors:  Ferrán Catalá-López; Manuel Ridao; Amparo Núñez-Beltrán; Ricard Gènova-Maleras; Adolfo Alonso-Arroyo; Rafael Aleixandre-Benavent; Miguel A Catalá; Rafael Tabarés-Seisdedos
Journal:  Syst Rev       Date:  2019-02-11

5.  Barriers and predictors of medication use for childhood ADHD: findings from a UK population-representative cohort.

Authors:  A E Russell; T Ford; G Russell
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-05-09       Impact factor: 4.328

6.  Evidence of potential overdiagnosis and overtreatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents: protocol for a scoping review.

Authors:  Luise Kazda; Katy Bell; Rae Thomas; Kevin McGeechan; Alexandra Barratt
Journal:  BMJ Open       Date:  2019-11-07       Impact factor: 2.692

7.  Community-Based Prevalence of Externalizing and Internalizing Disorders among School-Aged Children and Adolescents in Four Geographically Dispersed School Districts in the United States.

Authors:  Melissa L Danielson; Rebecca H Bitsko; Joseph R Holbrook; Sana N Charania; Angelika H Claussen; Robert E McKeown; Steven P Cuffe; Julie Sarno Owens; Steven W Evans; Lorraine Kubicek; Kate Flory
Journal:  Child Psychiatry Hum Dev       Date:  2021-06

8.  Phase II/III Study of Lisdexamfetamine Dimesylate in Japanese Pediatric Patients with Attention-Deficit/Hyperactivity Disorder.

Authors:  Hironobu Ichikawa; Tasuku Miyajima; Yushiro Yamashita; Masakazu Fujiwara; Akimasa Fukushi; Kazuhiko Saito
Journal:  J Child Adolesc Psychopharmacol       Date:  2019-11-12       Impact factor: 2.576

9.  Relative age and ADHD symptoms, diagnosis and medication: a systematic review.

Authors:  Josephine Holland; Kapil Sayal
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-10-06       Impact factor: 4.785

10.  Gender-Related Clinical Characteristics in Children and Adolescents with ADHD.

Authors:  Pietro De Rossi; Italo Pretelli; Deny Menghini; Barbara D'Aiello; Silvia Di Vara; Stefano Vicari
Journal:  J Clin Med       Date:  2022-01-13       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.